Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
February 2, 2023
Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance Cidara’s CD73 Oncology DFC Program
January 31, 2023
Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
January 31, 2023
scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update
January 31, 2023
Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101
January 27, 2023
Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
January 23, 2023
IDEAYA Announces Darovasertib Phase 2 Initiation in Neoadjuvant and Adjuvant Uveal Melanoma and Guidance for Clinical Data Update in Metastatic Uveal Melanoma
January 19, 2023
Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings
January 18, 2023
Wildcat Discovery Signs Joint Development Agreement with BMW Group to Speed Next Generation Battery Technology to the Market
January 18, 2023
Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List
January 18, 2023
Dianthus Therapeutics Strengthens Leadership Team with Appointment of Susan Kalled, Ph.D., as Chief Scientific Officer
« Previous Page
1
…
9
10
11
12
13
Next Page »